Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity

Nature Medicine

Volumn 2, Issue 8, 1996, Pages 899-905

  Waisman, Ari ^a   Ruiz, Pedro J ^a   Hirschberg, David L ^a,b   Gelman, Avraham ^a   Oksenberg, Jorge R ^c   Brocke, Stefan ^b   Mor, Felix ^a   Cohen, Irun R ^a   Steinman, Lawrence ^a,b  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MYELIN BASIC PROTEIN; PLASMID DNA; T LYMPHOCYTE RECEPTOR; THY 1 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ETIOLOGY; IMMUNIZATION; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PREVENTION; PRIORITY JOURNAL; THERAPY; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CYTOKINES; DNA; DNA PRIMERS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; LYMPHOCYTE ACTIVATION; MICE; MOLECULAR SEQUENCE DATA; RATS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TH1 CELLS; TH2 CELLS; VACCINES;

EID: 0029796099     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0896-899     Document Type: Article

References (37)

1. Zamvil, S. & Steinman, L. The T lymphocyte in autoimmune encephalomyelitis. Ann. Rev. Immunol. 8, 579-621 (1990).
2. Zamvil, S.S. et al. Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis. J. Exp. Med. 167, 1586-1596 (1988).
3. Acha-Orbea, H. et al. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54, 263-273 (1988).
4. Urban, J.L. et al. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54, 577-592 (1988).
5. Sakai, K. et al. Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein. Proc. Natl. Acad. Sci. USA 85, 8608-8612 (1988).
6. Vandenbark, A.A., Hashim, G. & Offner, H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341, 541-544 (1989).
7. Howell, M.D. et al. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246, 668-670 (1989).
8. Pardoll, D.M. & Beckerleg, A.M. Exposing the immunology of naked DNA vaccines. Immunity 3, 165-169 (1995).
9. Davis, H.L., Michel, M.L. & Whalen, R.G. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 2, 1847-1851 (1993).
10. Ulmer, J.B. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749 (1993).
11. Tang, D.C., DeVit, M. & Johnston, S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152-154 (1992).
12. Mosmann, T.R. & Coffman, R.L. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173 (1989).
13. Abbas, A.K. et al. Activation and function of CD4+ T-cell subsets, Immunol. Rev. 123, 5 (1991).
14. Xu, D. & Liew, F.Y. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology 84, 173-176 (1995).
15. Zamvil, S.S. et al. Multiple discrete encephalitogenic epitopes of the autoantigen myelin basic protein include a determinant for I-E class II-restricted T cells. J. Exp. Med. 168, 1181-1186 (1988).
16. Kuchroo, V.K. et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80, 707-718 (1995).
17. Powell, M.B. et al. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2, 539-544 (1990).
18. Racke, M.K. et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180, 1961-1966 (1994).
19. Wraith, D.C., McDevitt, H.O., Steinman, L. & Acha-Orbea, H. T cell recognition as the target for immune intervention in autoimmune disease. Cell 57, 709-715 (1989).
20. Ben-Nun, A., Wekerle, H. & Cohen, I.R. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 292, 60-61 (1981).
21. Lider, O., Reshef, T., Beraud, E., Ben-Nun, A. & Cohen, I.R. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science 239, 181-183 (1988).
22. Zhang, J., Medaer, R., Stinissen, P., Hafler, D. & Raus, J. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 261, 1451-1454 (1993).
23. Medaer, R., Stinissen, P., Truyen, L., Raus, J. & Zhang, J. Depletion of myelinbasic-protein autoreactive T cells by T-cell vaccination: Pilot trial in multiple sclerosis. Lancet 346, 807-808 (1995).
24. Bourdette, D.N. et al. Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic V beta 5.2 and V beta 6.1 CDR2 peptides. J. Immunol. 152, 2510-2519 (1994).
25. Chou, Y.K. et al. Immunity to TCR peptides in multiple sclerosis. II. T cell recognition of V beta 5.2 and V beta 6.1 CDR2 peptides. J. Immunol. 152, 2520-2529 (1994).
26. Chen, Y., Kuchroo, V.K., Inobe, J., Hafler, D.A. & Weiner, H.L. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 265, 1237-1240 (1994).
27. Lehmann, P.V., Forsthuber, T., Miller, A. & Sercarz, E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358, 155 (1992).
28. Brocke, S. et al. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379, 343-346 (1996).
29. Oksenberg, J.R. et al. Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362, 68-70 (1993).
30. Steinman, L. Escape from "horror autotoxicus": Pathogenesis and treatment of autoimmune disease. Cell 80, 7-10 (1995).
31. Wucherpfennig, K.W. et al. Shared human T cell receptor Vβ usage to immunodominant regions of myelin basic protein. Science 248, 1016 (1990).
32. Warren, K.G., Catz, I. & Steinman, L. The dominant T and B cell response in the central nervous system in multiple sclerosis is directed to myelin basic protein residues 86-99. Proc. Natl. Acad. Sci. USA 92, 11061-11065 (1995).
33. Steinman, L. Presenting an odd autoantigen. Nature 375, 739-740 (1995).
34. Steinman, L., Waisman, A. & Altman, D. Major T-cell responses in multiple sclerosis. Mol. Med. Today 1, 79-83 (1995).
35. Sambrook, J., Fritsch, E.F. & Maniatis, T. Molecular Cloning: A Laboratory Manual, edn. 2 (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1989).
36. Davis, H.L. & Jasmin, B.J. Direct gene transfer into mouse diaphragm. FEBS Lett. 333, 146-150 (1993).
37. Sakai, K. et al. Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein. J. Neuroimmunol. 19, 21-32 (1988).